Disease areas:
  • mouth and jaw
Last updated:
Author(s):
Su Kang Kim, Min Kyoung Kim, Sang Wook Kang, Ju Yeon Ban
Publish date:
9 March 2026
Journal:
International Journal of Molecular Sciences
PubMed ID:
41828728

Abstract

Periodontitis is a chronic infectious disease characterized by the destruction of the tooth-supporting tissues, including the gingiva, periodontal ligament, and alveolar bone, which may ultimately lead to tooth loss. However, blood-based biomarkers reflecting systemic inflammation in periodontitis remain poorly defined. We analyzed plasma proteomic data from the UK Biobank using Olink Explore proteomics to identify systemic protein signatures distinguishing chronic periodontitis patients (n = 90) from healthy controls (n = 2234). Among 2151 proteins passing quality control, 29 proteins showed significant differential expression (FDR < 1.0 × 10-5). Growth differentiation factor 15 (GDF15) exhibited the strongest upregulation (mean NPX: -0.183 to 0.157, effect size = 0.337, FDR = 2.82 × 10-12), followed by N-terminal pro-B-type natriuretic peptide (NT-proBNP) (effect size = 0.594), Interleukin-6 (IL-6) (effect size = 0.450), and Insulin-like growth factor binding protein-(4IGFBP4) (effect size = 0.269). Multiple TNF receptor superfamily members (TNFRSF1A/1B, TNFRSF10A/10B) and proteins involved in extracellular matrix remodeling (COL6A3, ADAM12) and vascular stress (ADM) were significantly elevated. In contrast, EGFR and DNER showed decreased expression. Protein-protein interaction network analysis revealed IL-6 as a central hub protein forming a tightly interconnected cluster with TNF receptor family members. These findings indicate systemic plasma protein profiles associated with chronic periodontitis within this population-based cohort. The identified proteins may provide a basis for future evaluation of blood-based biomarkers for chronic periodontitis, pending further validation.

Related projects

The goal of personalized medicine is the right drug, with the right dose, at the right time, for the right person. Pharmacogenomics may help us…

Institution:
Cipherome, Inc., United States of America

All projects